The anti-tumour ability of CD8+ T cells and immunotherapy sensitivity of BCa were significantly promoted when CD8+ T cells were co-cultured with circFAM13B overexpression T24 or UMUC3 cells (Figs. 2H–I). The gene discussed is CD8A; the disease is neoplasm.